Lung Cancer News

A lung nodule sized 30 mm3 or greater was found in 42% of adults in Northern Europe who reported either never smoking or former smoking, according to results published in Radiology.

The FDA approved amivantamab-vmjw plus lazertinib as first-line treatment for certain adults with non-small cell lung cancer.

Twelve months after indwelling pleural catheter insertion vs. chemical pleurodesis for malignant pleural effusions, the average cost of health care was lower, according to results published in Annals of the American Thoracic Society.

The FDA expanded the approval of durvalumab for lung cancer.

A randomized phase 3 trial designed to compare two combinations for first-line treatment of lung cancer has been halted after an interim analysis revealed no survival benefit and more toxicity with the experimental regimen.

Among adults with newly identified small pulmonary nodules, 48.8% reported emotional distress and 42.3% reported general anxiety, according to results published in CHEST.

Having an education level of high school or less heightened the risk for loss to follow-up among individuals eligible for lung cancer screening, according to a letter published in Annals of the American Thoracic Society.

During lung cancer screening selection assessments, clinicians influenced the decision of screening inappropriateness more than patient factors, according to results published in American Journal of Respiratory and Critical Care Medicine.

Today is World Lung Cancer Day.

A blood biomarker used to identify benign vs. malignant pulmonary nodules displayed “excellent” performance regardless of sex, smoking status, screen detection and nodule size, according to a research letter published in CHEST.